To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes

Table 4 Logistic regression analysis of risk factors for decreased EGFR in diabetic nephropathy patients

Features	β	S.E	Wald	P	OR	95%CI
Features	β	S.E	Wald	P	OR	lower	upper
Intercept	-4.1133	1.0125	16.5041	< 0.001	-	-	-
PVD	0.8220	0.3205	6.5768	0.010	2.275	1.214	4.264
HDL	-0.9522	0.2604	13.3707	< 0.001	0.386	0.232	0.643
Fatty Liver	2.0564	0.4805	18.3154	< 0.001	7.818	3.048	20.050
β2-MG	1.3823	0.2186	39.9703	< 0.001	3.984	2.595	6.115
FCP	-0.2836	0.1057	7.2030	0.007	0.753	0.612	0.926
Systolic pressure	1.4531	0.2233	23.3812	< 0.001	4.398	3.272	7.723

Note: PVD, peripheral vascular disease; HDL, high density lipoprotein; β 2-MG, beta-2-microglobulin; FCP, fasting C-peptide

ISSN: 1472-6823